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Summary: A method is described for the quantitative isolation and estimation of the four glycosphingolipid fractions
from 10 ml of human plasma. The procedure consists of acetylation of the total lipids after extraction, separation of
acetylated glycosphingolipids from non-glycolipids on a Florisil column, deacetylation, dialysis in water, separation
of the single fractions by thin-layer chromatography on silica gel, and quantitative analysis of each glycosphingolipid
by sulfuric acid-orcinol reagent, carried out in the presence of silica gel. The concentrations of the four glycosphingo-
lipids in human plasma derived from a group of 23 healthy subjects are presented. The procedure described is suffici-
ently sensitive for clinical investigation.
Quantitative Bestimmung der Glycosphingolipide im menschlichen Blutplasma
Zusammenfassung: Über eine Methode zur quantitativen Isolierung und Bestimmung der vier neutralen Glycosphingo-
lipidfraktionen aus 10 ml menschlichem Blutplasma wird berichtet. Das Verfahren besteht aus: Acetylierung der extra-
hierten Gesamtlipide, Abtrennung der acetylierten Glycosphingolipide durch Säulenchromatographie an Florisil, Deace-
tylierung, Dialyse gegen Wasser, Auftrennung der einzelnen Fraktionen durch Dünnschichtchromatographie auf Kiesel-
gelplatten und quantitative Bestimmung der verschiedenen Glycosphingolipide im Schwefelsäure-Orcinol-Test in
Gegenwart von Kieselgel. Die ermittelten Konzentrationen der vier Glycosphingolipide in einem Kollektiv von
23 gesunden Personen werden mitgeteilt. Das beschriebene Verfahren ist empfindlich und geeignet für klinische Unter-
suchungen.
Introduction
Four fractions of neutral glycosphingolipids have been
isolated from human plasma and characterized: mono-
hexosyl (glucpsyl) cerainide, dihexosyl (lactosyl or
galactosyl-glucosyl) ceramide, trihexosyl (galactosyl-
gälactosyl-glucosyl) ceramide, and tetrahexosyl (N-
acetylgalactosaminyl-galactosyl>galactosyl-glucosyl)
ceramide (1, 2). Abnormalities of glycosphingolipid
metabolism that occur in several sphingolipidoses such
as Gaucher's disease, lactosyl-ceramidpsis or/dairy's
disease and secondarily in other diseases like hyper-
lipoprpteinemia<(3,4, 5) have led to an increasing
interest in the behavior and physiological function of
the glycosyl ceramides in human blood. Previous studies
on the isolation of single glycpsyl ceramides from
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human blood included a variety of Chromatographie
steps and required large volumes (17 1) of plasma (1).
Vance &Sweeley (2) presented a method, including
gas-liquid-chromatography, for the quantitative
determination of the glycosyl ceramides in human
plasma requiring 50 ml of plasma. Saito &Hakomori (6)
introduced a quantitative isolation of total glycosphingo-
lipids from animal cells using column chromatography on
Florisil of the peracetylated glycolipids, but the estima-
tion of the carbohydrate moiety by gas-liquid-chromato-
graphy is necessary. Neskovic et al. (7) described the
analysis of the isolated glycolipids from brain without
previous elution from silica gel by a spectrophotometric
assay, employing the orcinol method of Svennerholm (8).
This paper describes the quantitative isolation and deter-
mination of the four glycosphingolipids derived from
10 ml plasma, using among other steps, chromatography
on Florisil of the acetylated glycolipids and estimation
of the carbohydrate part by the orcinol reagent.
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Materials and Methods
Heparinized blood samples were obtained from 23 healthy
subjects (10 males, 13 females, age: χ = 32a, 22-74) after a
fasting period of 12 hours. The blood samples were centrifuged
for 20 min at 1700# to separate the plasma.
Chemicals
Orcinol, D(+)-galactose and /)(+)-glucose were obtained from
E. Merck AG (Darmstadt, Germany). Florisil (60-100 mesh)
was purchased from Serva (Heidelberg, Germany). Refer-
ence substances of glucosyl-, lactosyl-, trihexosyl- and tetra-
hexosyl ceramide were generous gifts from Prof. Dr. W. Gielen,
Biochemische Pharmakologie des Pharmakologischen Insti-
tutes, Universit t K ln (Germany). Cerebroside (galactosyl
ceramide) was purchased from „Applied Science Laboratories,
Inc., USA", and synthetic glucosyl- and lactosyl ceramide were
obtained from "Research Division Miles Laboratories, Inc.,
Frankfurt/Main" (Germany). All other chemicals used were
analytical grade reagents obtained from commercial sources.
Orcinol reagent
140 ml of concentrated sulfuric acid were diluted with distilled
water under cooling to a final volume of 200 ml. Before use
100 mg orcinol were dissolved in 100 ml of cold diluted sulfuric
acid.
in the cold room. After separation the residue (crude lipid
extract) was dissolved in 1.8 ml of dried pyridine and 0.6 nil
of acetic anhydride. After standing at room temperature for
18 hours 300 ml of dry toluene were added. The solvents were
completely evaporated. The dry residue was dissolved in 1.5 ml
of n-hexane-l,2-dichloroethane (volumes, 1 ml + 4 ml) and put
on a column (1 X 25 cm, capacity 9.5 g) of deactivated Florisil
(magnesia-silica gel, 60-100 mesh) prepared with the same sol-
vent. Subsequently the column was eluted stepwise with 130 ml
each of the following solvents: n-hexane-l,2-dichloroethane
(volumes, 1 ml+ 4 ml), 1,2-dichloroethane, 1,2-dichloroethane-
acetone (volumes, 1 ml+ 1 ml), 1,2-dichloroethane-methanol-
water (volumes, 2 ml + 8 ml + 1 ml). The acetylated glycosphingo-
lipids were eluted \vith 1,2-dichlorqethane-acetone. This fraction
containing the acetylated glycosphingolipids was evaporated to
dryness in vacuo. The residue was dissolved in 1.2 ml chloro-
form-methanol (volumes, 2 ml + 1 ml) and 0.3 ml of 5 g/1
sodium methoxide in methanol. After standing for 30 min at
25 °C the solution was neutralized by addition of 0.6 ml ethyl
acetate, evaporated to dryness, emulsified in 1.5 ml water and
0,5 ml "theoretical upper phase" (chloroform-methanol-1 g/1
NaCl, (volumes, 1 ml + 10 ml)), transferred in a dialysis menv
brane (Visking, φ 7 mm, diameter of pores 1.5-2.0 nm,
obtained from Serva, Heidelberg, Germany), and dialysed
against 200 volumes of ice water overnight. The dialysed solu-
tion was evaporated to dryness in a rotatory evaporator and
kept in a desiccator over phosphorus pentoxide. The dried
residue was dissolved in 0.15-0.2 ml of chloroform-methanol
(volumes, 2 ml + 1 ml) for analysis by thin layer chromatography.
Commercially available thin-layer plates (20 X 20 cm, layer thick-
ness 0.25 mm, silica gel 60, obtained from E. Merck, Darmstadt)
Procedure
Isolation ofglycosyl ceramides
Ten ml plasma were mixed with 200 ml of chloroform-methanol
(volumes, 200 ml + 100 ml) (scheme 1). After standing for 2 hours
at room temperature the mixture was filtered, and the residue
was washed with 3 ml of chloroform-methanol (volumes,
2 ml + 1 ml). The combined extracts were mixed thoroughly with













(volumes, 200 ml+ 100 ml)
(20 vol.) with distilled water
(1/5 voL)
pyridine — acetic anhydride
1. n-hexane - 1,2-dichloro-
ethane
2. 1,2-dichloroethane
3. acetone - 1,2-dichloro-
ethane
sodium methoxide in methanol,
neutralized with ethyl acetate
1.7 ml distilled water
0.5 ml "theoretical upper phase"
0.15 ml chloroform-methanol





Scheme 1. Summary of glycosphingolipid isolation from human
plasma.
Orig in
Fig. I. Thin layer criromatogram of isolated glycosphingo-
lipids from plasma of a patient with rnprbus F bry.
Solvent: Chloroform-methanol-water (volumes, 65 ml
+ 25 ml + 4 ml). Visualized with iodine vapour.
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were used. Prior to use the plates were activated for 30 min at
110 °C. The samples (and reference substances) were spotted
1.5 cm from the lower edge of the plate as a 2 cm long band.
The chromatogram was developed using chloroform-methanol-
water (volumes, 65 ml + 25 ml + 4 ml) as the mobile phase in
saturated tanks. The solvents were allowed to ascend at room
temperature to a distance of 17 cm from the origin. After
chromatography the plates were dried at room temperature.
The iipid spots were visualized by iodine vapour (fig. 1).
Rectangular fields enclosing the spots and corresponding blank
zones were marked with a fine spatula. Mono-, di~, tri- and
tetrahexosyl ceramides were identified by comparison with
reference substances chromatographed on the same plate.
Determination of glycosyl ceramides
After removal of the iodine by volatilization, the marked areas of
adsorbent were scraped off and transferred to glass tubes. The
adsorbent pieces were minced, and 3 ml of cold orcinol reagent
were added. After thoroughly mixing for 30 s with a mechanical
agitator the tubes were incubated at 80 °C for 20 min. Thereafter
the tubes were chilled in ice water, mixed with a mechanical agita-
tor, and the silica gel was removed by low speed centrifugation.
The absorbance was estimated at 505 nm. A sample blank was
taken using 3 ml of orcinol reagent. The absorbances of the
corresponding control areas were subtracted from the test
samples. Aliquots of galactose (0.05, 0.1,0.2 μιηοΐ) were treated
by the same colorimetric procedure.
The hexose contents of the isolated glycosphingolipids were
calculated from the standard curves, based on the relative molar
absorbances of glucose and galactose (fig. 2 and 3). Galactosamine
gives no reaction with orcinol (7, 8). The hexoses in the four iso-
lated glycosphingolipids were assumed to be as follows: mono-
hexosyl ceramide-glucose; dihexosyl ceramide - glucose-galactose;
trihexosyl ceramide - glucose-galactose-galactose; tetrahexosyl
ceramide — glucose-galactose-galactose-N-acetylgalactosamine
(2). In control series this assumption was confirmed after tri-
methylsilylation of the carbohydrate moieties by gas-liquid-
chromatography of the trimethylsilyl methyl glycosides (9,10)
(fig. 4). The portion of galactose in monohexosyl ceramide is
about 5 %.
Results and Discussion
Table 1 represents the concentrations of glycosyl
ceramides in human plasma of 23 healthy subjects.
Glucosyl ceramide was found to be the predominant




















Fig. 3. Calibration curves for glucose-galactose ((a) μιηοΐ, 1 + 1)
(dihexosyl ceramide) and glucose-galactose ((b) μπιοί,
1 + 2) (trihexosyl and tetrahexosyl ceramide), deter-
mined by the orcinol reaction. Mean ± standard deviation,
η = 6.
7.5 15





Fig. 4. Gas chromatogram of trimethylsilyl methyl glycosides
of glucose and galactose from isolated plasma dihexosyl
ceramide, with added mannitol (internal standard).
Column of 3% SE-30 at 170 °C.
Packard model 7720.
Tab. 1. Concentration of glycosyl ceramides in human plasma of
healthy subjects (n = 23).




Fig. 2. Calibration curves for galactose (a) and glucose (b)
determined by the orcinol reaction. The glucose curve
is used for monohexosyl ceramide determination, the






















J. Clin. Chem. Clin. Biqchem. / Vol. IS., 1977 / No. 5 21*
296 Atzpodien and Kremer: Quantitative determination of glycosphingolipids in human plasma
Tab. 2. Duplicate analyses of 10 ml plasma from eight indi-
viduals,




























































































of decreasing concentration, dihexosyl ceramide,
tetrahexosyl ceramide and trihexosyl ceramide. This
is in good agreement with the results of Vance &Swee-
ley (2). Our average concentrations of plasma glyco^
sphingolipids correspond to the values obtained by
other laboratories from only few subjects and with
different methods (2, 11, 12). The recoveries of added
glucosyl ceramide and lactosyl ceramide, estimated
according to our procedure, were 96% for glucosyl
ceramide and 89% for lactosyl ceramide, respectively.
The precision of the method was tested in duplicate
analyses of plasma iri eight individuals. The results
are presented in table 2. Standard deviations were
calculated by performing the analysis of variance with
eight groups. They range from about 7% of the mean
for mono? and dihexosyl ceramide to 13—14% for tri-
hexosyl and tetrahexosyl ceramide.
The procedure described for the isolation and estimation
of glycosphingqlipids in plasma is sufficiently sensitive
for routine work with 10 ml-plasma aliquots. The
advantage of this method in clinical investigation is the
small plasma volume needed and the estimation of the
carbohydrate parts without application of the irritable
arid time consuming procedure of gas chromatography.
The method described allows the diagnostic detection
of elevated sphingolipids in lipidpses like morbus Fabry
(13) and permits further clinical investigations of glyco-
sphingolipid metabolism (4, 5).
Acknowledgement
The careful technical assistance of Mrs. F. Popp is gratefully
acknowledged. We wish to thank Dipl. Math. G. M ller (Rechen-
zentrum der Universit t Mainz) for performing the analysis of
variance.
References
1. Svennerholm, E. & Svennerholm, L. (1963), Biochim.
Biophys. Acta 70, 432-441.
2. Vance, D. E. & Sweeley, C. C. (1967), J. Lipid Res. 8,
621-630.
3. Kuske, T. T. (1972), Ann. Clin. Lab. Sei. 2, 268-273.
4. Kremer, G. J., Atzpodien, W. & Schnellbacher, E. (1975),
Klin. Wochenschr. 53, 637-638.
5. Atzpodien, W., Kremer, G. J. & Schnellbacher, E. (1976),
Klin. Wochenschr. 54, 585-590.
6. Saito, T. & Hakomori, S. (1971), J. Lipid Res. 12, 257-259.
7. Neskovic, N., Sarlieve, L., Nussbaum, J. L., Kostic, D.
& Mandel, P. (1972), Clin. Chim. Acta 38,147-153.
8. Svennerholm, L. (1956), J. Neurochem. 7, 42-53.
9. Laine, R. A., Esselman, W. J. & Sweeley, C. C. (1972), in:
Methods in Enzymology (ed. S. P. Colowick and N. O.
Kaplan), vol. XXVIII, B, 159-167.
10. Chambers, R. E. & Clamp, J. R. (1971), Biochem. J. 725,
1009-1018.
11. Dawson, G. (1972), Ann. Clin. Lab. Sei. 2, 274-284.
12. Philippart, M. (1972), Adv. Exp. Med. Biol. 25, 231-254.
13. Atzpodien, W., Kremer, G. J., Schnellbacher, E., Denk, R.,
H ferkamp, G. & Bierbach, H. (1975), Dtsch. Med. Wochen-
schr. 100, 423-426.
Dr. W. Atzpodien, Ass. Prof.
II. Medizinische Klinik und Poliklinik der Universit t
Langenbeckstra e l
D-6500 Mainz
Prof. Dr. G: J. Kremer
Innere Abteilung
St. Josefs-Krankenhaus
M hlheimer Stra e 83
ΓΜ200 Oberhausen
J. Clin. Chem, Clin. Biochem. / Vol. 15,1977 / No. 5
